Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22349989 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation
Conditions: Coronary Artery Disease;   Dyslipidemia
Interventions: Drug: RVX000222;   Drug: Placebo RVX000222

Indicates status has not been verified in more than two years